The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global General Anaesthetic Medication Market Research Report 2025
Synopsis
General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.
Global General Anaesthetic Medication market is projected to reach US$ 4983.4 million in 2029, increasing from US$ 3926 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole General Anaesthetic Medication market research.
The general anesthetic for surgery market is primarily driven by the increasing number of surgical procedures performed globally and the growing demand for safe and effective anesthesia to ensure patient comfort and successful surgical outcomes. General anesthesia plays a crucial role in inducing a reversible state of unconsciousness and analgesia during surgery, allowing surgeons to perform complex procedures with minimal patient discomfort. Moreover, advancements in anesthesia delivery systems and monitoring technologies contribute to the market's growth by enhancing anesthesia administration precision and patient safety. However, the market also faces challenges, including the potential for adverse reactions and complications associated with general anesthesia, such as postoperative nausea and vomiting (PONV) or rare anesthetic-related reactions. Ensuring patient safety and minimizing the risk of adverse events remain key challenges for healthcare providers and anesthesiologists. Additionally, the availability and accessibility of anesthesia services in remote or underserved regions can be limited, hindering access to surgical care for some patients.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global General Anaesthetic Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang
Segment by Type
Propofol
Sevoflurane
Remifentanil
Etomidate
Isoflurane
Other
Segment by Application
Intravenous Anesthetics
Inhalational Anesthetics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The General Anaesthetic Medication report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management. General anesthesia is used in various cardiac surgeries, hip and knee replacement surgeries, cancer surgeries, and gastro-intestinal surgeries.
Global General Anaesthetic Medication market is projected to reach US$ 4983.4 million in 2029, increasing from US$ 3926 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole General Anaesthetic Medication market research.
The general anesthetic for surgery market is primarily driven by the increasing number of surgical procedures performed globally and the growing demand for safe and effective anesthesia to ensure patient comfort and successful surgical outcomes. General anesthesia plays a crucial role in inducing a reversible state of unconsciousness and analgesia during surgery, allowing surgeons to perform complex procedures with minimal patient discomfort. Moreover, advancements in anesthesia delivery systems and monitoring technologies contribute to the market's growth by enhancing anesthesia administration precision and patient safety. However, the market also faces challenges, including the potential for adverse reactions and complications associated with general anesthesia, such as postoperative nausea and vomiting (PONV) or rare anesthetic-related reactions. Ensuring patient safety and minimizing the risk of adverse events remain key challenges for healthcare providers and anesthesiologists. Additionally, the availability and accessibility of anesthesia services in remote or underserved regions can be limited, hindering access to surgical care for some patients.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global General Anaesthetic Medication market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Aspen Pharma
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Yichang Humanwell
Nhwa
Hengrui
Xi'an Libang
Segment by Type
Propofol
Sevoflurane
Remifentanil
Etomidate
Isoflurane
Other
Segment by Application
Intravenous Anesthetics
Inhalational Anesthetics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The General Anaesthetic Medication report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global General Anaesthetic Medication Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Propofol
1.2.3 Sevoflurane
1.2.4 Remifentanil
1.2.5 Etomidate
1.2.6 Isoflurane
1.2.7 Other
1.3 Market by Application
1.3.1 Global General Anaesthetic Medication Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Intravenous Anesthetics
1.3.3 Inhalational Anesthetics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global General Anaesthetic Medication Market Perspective (2018-2029)
2.2 General Anaesthetic Medication Growth Trends by Region
2.2.1 Global General Anaesthetic Medication Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 General Anaesthetic Medication Historic Market Size by Region (2018-2023)
2.2.3 General Anaesthetic Medication Forecasted Market Size by Region (2024-2029)
2.3 General Anaesthetic Medication Market Dynamics
2.3.1 General Anaesthetic Medication Industry Trends
2.3.2 General Anaesthetic Medication Market Drivers
2.3.3 General Anaesthetic Medication Market Challenges
2.3.4 General Anaesthetic Medication Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top General Anaesthetic Medication Players by Revenue
3.1.1 Global Top General Anaesthetic Medication Players by Revenue (2018-2023)
3.1.2 Global General Anaesthetic Medication Revenue Market Share by Players (2018-2023)
3.2 Global General Anaesthetic Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by General Anaesthetic Medication Revenue
3.4 Global General Anaesthetic Medication Market Concentration Ratio
3.4.1 Global General Anaesthetic Medication Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by General Anaesthetic Medication Revenue in 2022
3.5 General Anaesthetic Medication Key Players Head office and Area Served
3.6 Key Players General Anaesthetic Medication Product Solution and Service
3.7 Date of Enter into General Anaesthetic Medication Market
3.8 Mergers & Acquisitions, Expansion Plans
4 General Anaesthetic Medication Breakdown Data by Type
4.1 Global General Anaesthetic Medication Historic Market Size by Type (2018-2023)
4.2 Global General Anaesthetic Medication Forecasted Market Size by Type (2024-2029)
5 General Anaesthetic Medication Breakdown Data by Application
5.1 Global General Anaesthetic Medication Historic Market Size by Application (2018-2023)
5.2 Global General Anaesthetic Medication Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America General Anaesthetic Medication Market Size (2018-2029)
6.2 North America General Anaesthetic Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America General Anaesthetic Medication Market Size by Country (2018-2023)
6.4 North America General Anaesthetic Medication Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe General Anaesthetic Medication Market Size (2018-2029)
7.2 Europe General Anaesthetic Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe General Anaesthetic Medication Market Size by Country (2018-2023)
7.4 Europe General Anaesthetic Medication Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific General Anaesthetic Medication Market Size (2018-2029)
8.2 Asia-Pacific General Anaesthetic Medication Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific General Anaesthetic Medication Market Size by Region (2018-2023)
8.4 Asia-Pacific General Anaesthetic Medication Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America General Anaesthetic Medication Market Size (2018-2029)
9.2 Latin America General Anaesthetic Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America General Anaesthetic Medication Market Size by Country (2018-2023)
9.4 Latin America General Anaesthetic Medication Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa General Anaesthetic Medication Market Size (2018-2029)
10.2 Middle East & Africa General Anaesthetic Medication Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa General Anaesthetic Medication Market Size by Country (2018-2023)
10.4 Middle East & Africa General Anaesthetic Medication Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Aspen Pharma
11.1.1 Aspen Pharma Company Detail
11.1.2 Aspen Pharma Business Overview
11.1.3 Aspen Pharma General Anaesthetic Medication Introduction
11.1.4 Aspen Pharma Revenue in General Anaesthetic Medication Business (2018-2023)
11.1.5 Aspen Pharma Recent Development
11.2 Fresenius-Kabi
11.2.1 Fresenius-Kabi Company Detail
11.2.2 Fresenius-Kabi Business Overview
11.2.3 Fresenius-Kabi General Anaesthetic Medication Introduction
11.2.4 Fresenius-Kabi Revenue in General Anaesthetic Medication Business (2018-2023)
11.2.5 Fresenius-Kabi Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie General Anaesthetic Medication Introduction
11.3.4 AbbVie Revenue in General Anaesthetic Medication Business (2018-2023)
11.3.5 AbbVie Recent Development
11.4 Baxter Healthcare
11.4.1 Baxter Healthcare Company Detail
11.4.2 Baxter Healthcare Business Overview
11.4.3 Baxter Healthcare General Anaesthetic Medication Introduction
11.4.4 Baxter Healthcare Revenue in General Anaesthetic Medication Business (2018-2023)
11.4.5 Baxter Healthcare Recent Development
11.5 B.Braun
11.5.1 B.Braun Company Detail
11.5.2 B.Braun Business Overview
11.5.3 B.Braun General Anaesthetic Medication Introduction
11.5.4 B.Braun Revenue in General Anaesthetic Medication Business (2018-2023)
11.5.5 B.Braun Recent Development
11.6 Maruishi
11.6.1 Maruishi Company Detail
11.6.2 Maruishi Business Overview
11.6.3 Maruishi General Anaesthetic Medication Introduction
11.6.4 Maruishi Revenue in General Anaesthetic Medication Business (2018-2023)
11.6.5 Maruishi Recent Development
11.7 Piramal
11.7.1 Piramal Company Detail
11.7.2 Piramal Business Overview
11.7.3 Piramal General Anaesthetic Medication Introduction
11.7.4 Piramal Revenue in General Anaesthetic Medication Business (2018-2023)
11.7.5 Piramal Recent Development
11.8 Hikma Pharmaceuticals
11.8.1 Hikma Pharmaceuticals Company Detail
11.8.2 Hikma Pharmaceuticals Business Overview
11.8.3 Hikma Pharmaceuticals General Anaesthetic Medication Introduction
11.8.4 Hikma Pharmaceuticals Revenue in General Anaesthetic Medication Business (2018-2023)
11.8.5 Hikma Pharmaceuticals Recent Development
11.9 Yichang Humanwell
11.9.1 Yichang Humanwell Company Detail
11.9.2 Yichang Humanwell Business Overview
11.9.3 Yichang Humanwell General Anaesthetic Medication Introduction
11.9.4 Yichang Humanwell Revenue in General Anaesthetic Medication Business (2018-2023)
11.9.5 Yichang Humanwell Recent Development
11.10 Nhwa
11.10.1 Nhwa Company Detail
11.10.2 Nhwa Business Overview
11.10.3 Nhwa General Anaesthetic Medication Introduction
11.10.4 Nhwa Revenue in General Anaesthetic Medication Business (2018-2023)
11.10.5 Nhwa Recent Development
11.11 Hengrui
11.11.1 Hengrui Company Detail
11.11.2 Hengrui Business Overview
11.11.3 Hengrui General Anaesthetic Medication Introduction
11.11.4 Hengrui Revenue in General Anaesthetic Medication Business (2018-2023)
11.11.5 Hengrui Recent Development
11.12 Xi'an Libang
11.12.1 Xi'an Libang Company Detail
11.12.2 Xi'an Libang Business Overview
11.12.3 Xi'an Libang General Anaesthetic Medication Introduction
11.12.4 Xi'an Libang Revenue in General Anaesthetic Medication Business (2018-2023)
11.12.5 Xi'an Libang Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
